Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction.
about
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanismsLysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expressionA multi-targeted approach to suppress tumor-promoting inflammationResveratrol as a natural anti-tumor necrosis factor-α molecule: implications to dendritic cells and their crosstalk with mesenchymal stromal cellsChrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cellsSubstituted trans-stilbenes can inhibit or enhance the TPA-induced up-regulation of activator protein-1.Mmp-9, a potential target for cerebral ischemic treatment.Resveratrol blunts tumor necrosis factor-alpha-induced monocyte adhesion and transmigration.Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinaJapanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-κB signalling dependent on MAPKs and reactive oxygen species.6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation.The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation.Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanismResveratrol inhibits Cdk5 activity through regulation of p35 expressionEstrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cellsEUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses.Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases.Heat shock proteins are important mediators of skeletal muscle insulin sensitivityPredicting the physiological relevance of in vitro cancer preventive activities of phytochemicals.Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention.Inhibition of transcriptional activity of c-JUN by SIRT1.Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy.On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes.Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.Cancer chemoprevention by polyphenols and their potential application as nanomedicine.New approaches to selectively target cancer-associated matrix metalloproteinase activity.Plant natural products: from traditional compounds to new emerging drugs in cancer therapy.Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.Polyphenol compounds and PKC signaling.Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol.The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.Role of Na+/H+ exchanger in resveratrol-induced growth inhibition of human breast cancer cells.Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
P2860
Q24648759-F883E267-829E-4166-A99E-AC0EF6900F2FQ28299091-803F0A5B-8A5E-4D69-ABB6-802F2E7C5DBCQ28393278-C2B1EC59-17E3-417D-A5BE-6A8E4E77E5B8Q28540693-9A265CE3-2BA1-46AF-B084-71313FA753EBQ28546405-957F63D3-4257-45EE-929E-D37CD6658EEEQ33383634-44C60F40-D26B-4068-8DC4-39BC66851343Q33612510-97F42E4B-C661-4B10-9886-271CEAE47A12Q33767574-8DB3324D-701B-4399-8804-71B0BF1F6145Q34113009-58804B85-FAB5-42F6-B246-12DAE7A3CD6EQ34442336-846382F1-5AF9-4AE5-A64D-0740AB76A025Q34442414-FBE7FCBD-3CA1-4DD6-A07C-3F05F0A2B2EEQ34599215-2566B9FC-52D3-4096-A8B5-2A6D2897FACBQ34768276-190019A3-39C4-4EA3-8381-F28CEB630C8BQ35190978-19BBE479-6358-4E4E-9C52-35C57D4EA404Q35540785-F1E56863-25B8-4FE0-A462-2E14909C04C3Q35668666-6146C3A0-DD5F-4C18-A493-682611373F7BQ35854435-17E2AEA1-AE28-4A3B-ACFD-41D78B16FC64Q35865088-9B4FF6E3-9293-4556-AFD3-BB5E9647B7B2Q35911136-91473CD6-FB42-4689-93DC-D4DA983614E5Q36896750-DFB4FDC5-DB50-4774-8F63-262D1E66E4B9Q36920740-FA7B7DB5-CEB7-4194-8855-DA5BBF5AB9A3Q37000698-217BEFEF-9EA4-44F1-BA72-B137626B2A02Q37069844-F48BF750-CF49-46CF-B94D-C3758B7EF815Q37148781-950119AD-873D-4546-A2C8-E436E68C2C7FQ37307247-3D9CEA44-6A8A-46F9-8859-718406765E03Q37616627-1DAC3605-9685-4176-92AD-2DDE1111616CQ37662196-9FB34950-57ED-4ABF-A60A-51AC4BAFF3C9Q37780645-250A55A1-1AF1-4A12-914C-CE8578199582Q38093653-7EE5AEFA-77C5-4F30-BE3B-02C298ABBF19Q38261141-C189A8D3-9786-4C2E-99FD-7BD335FDEFD6Q38265836-B266716A-9D66-46E5-BC16-EEA0950D38F8Q38650926-DA0E8DFD-E7E8-418B-8B1E-1CA8576D8F99Q38846159-F12F0734-EB95-4BA3-A816-C54E8558705CQ38934412-C431D3BD-4960-4CE9-AED8-6772FE81E195Q39037806-1A867057-BB2C-4D1C-8F7A-48CBBB251C0AQ39381116-C255DE67-A322-4980-AE9F-235B1F74953FQ39411440-90FA8B82-E240-431B-8B64-BAD499D0BB54Q39614487-3D1203E8-1C1A-4376-879F-CD8EDF3932E5Q39700912-8730661A-1EF1-4B6E-AE94-D17C66C2EBE6Q39743835-33FFB92B-EEEF-4E55-82A0-6E2ACCFEFDDB
P2860
Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@ast
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@en
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@nl
type
label
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@ast
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@en
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@nl
prefLabel
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@ast
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@en
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@nl
P2093
P356
P1433
P1476
Resveratrol inhibits phorbol m ...... PKC delta signal transduction.
@en
P2093
Do Sik Min
Jong-Soo Chang
Jong-Wook Park
Ju-Hyung Woo
Jun Hee Lim
Seong-Il Suh
Taeg Kyu Kwon
Young Han Lee
Young-Ho Kim
P2888
P304
P356
10.1038/SJ.ONC.1207307
P407
P577
2004-03-01T00:00:00Z
P5875
P6179
1049721637